Anti-Histone H3.3 (phospho S31) antibody [EPR1873]
- RabMAb
- Recombinant
- What is this?
3
(4 Reviews)
|
(18 Publications)
Rabbit Recombinant Monoclonal H3 phospho S31 antibody. Suitable for IHC-P, Dot, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Synthetic peptide samples. Cited in 18 publications.
View Alternative Names
H3.3A, H3F3, H3F3A, PP781, H3-3B, H3.3B, H3F3B, H3-3A, Histone H3.3, H3S31p
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Histone H3.3 (phospho S31) antibody [EPR1873] (AB92628)
Intracellular Flow Cytometry analysis of Hela (human cervix adenocarcinoma) cells treated with 100 ng/ml Nocodazole for 18 hours, labeling Histone H3.3 with purified ab92628 at 1/150 dilution (10μg/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti-rabbit IgG (Alexa Fluorr® 488) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control. Untreated control - Hela (human cervix adenocarcinoma) cells untreated with 100 ng/ml Nocodazole for 18 hours (Green).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Histone H3.3 (phospho S31) antibody [EPR1873] (AB92628)
Paraffin-embedded human cervical carcinoma labelled with ab92628 at 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Histone H3.3 (phospho S31) antibody [EPR1873] (AB92628)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% tritonX-100 HeLa (Human epithelial cell line from cervix adenocarcinoma) cells, LP treated and non-treated, labeling anti-Histone H3.3 (phospho S31) with ab92628 at 1/500 dilution followed by Goat anti-Rabbit secondary IgG Alexa Fluor® 488 (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing nuclear staining on M phase of HeLa cells, then the signal decreased after LP treatment.
For the pan antibody, there was no great difference after LP treatment. The data showed mostly nuclear staining.
- WB
Supplier Data
Western blot - Anti-Histone H3.3 (phospho S31) antibody [EPR1873] (AB92628)
Blocking/dilution buffer : 2% BSA/TBST
All lanes:
Western blot - Anti-Histone H3.3 (phospho S31) antibody [EPR1873] (ab92628) at 1/1000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 15 µg
Lane 2:
Whole cell lysate from HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with 100ng/ml of nocodazole for 18 hours at 15 µg
Lane 3:
Whole cell lysate from HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with 100ng/ml of nocodazole for 18 hours. Membrane incubated with phosphatase at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 15 kDa
false
Exposure time: 15s
- WB
Unknown
Western blot - Anti-Histone H3.3 (phospho S31) antibody [EPR1873] (AB92628)
All lanes:
Western blot - Anti-Histone H3.3 (phospho S31) antibody [EPR1873] (ab92628) at 1/1000 dilution
Lane 1:
HeLa cell lysate untreated at 10 µg
Lane 2:
HeLa cell lysate treated with Calyculin A at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 15 kDa
false
- WB
AbReview30108****
Western blot - Anti-Histone H3.3 (phospho S31) antibody [EPR1873] (AB92628)
Representative western blot detecting Histone H3.3 (phospho S31) using ab92628 at 1/3000 dilution.
Recombinant Histone H3.3 protein was treated with recombinant kinase and 200 μM ATP for the indicated times. 0.2 μg of protein was loaded to each lane and phosphorylated Histone H3.3 was detected using ab92628. An HRP-conjugated goat anti-rabbit polyclonal (1/20000) was used as the secondary antibody
All lanes:
Western blot - Anti-Histone H3.3 (phospho S31) antibody [EPR1873] (ab92628)
Predicted band size: 15 kDa
false
This image is courtesy of an anonymous Abreview
- Dot
Unknown
Dot Blot - Anti-Histone H3.3 (phospho S31) antibody [EPR1873] (AB92628)
Dot Blot analysis of Lane 1 : Histone H3.3 (pS31) phospho peptide and Lane 2 : Histone H3.3 non-phospho peptide labeling Histone H3.3 (phospho S31) with ab92628 at 1/1000 dilution. 5% NFDM/TBST was used as the diluting and blocking buffer.
ab97051 Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated was used as the secondary antibody at 1/100000 dilution. Exposure time : 10 seconds.
Related conjugates and formulations (3)
-
Anti-Histone H3.3 (phospho S31) antibody [EPR1873] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Histone H3.3 (phospho S31) antibody [EPR1873]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Histone H3.3 (phospho S31) antibody [EPR1873]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (18)
Recent publications for all applications. Explore the full list and refine your search
Laboratory animal research 41:25 PubMed40993770
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical genetics 63:5394-5414 PubMed39656403
2024
Applications
Unspecified application
Species
Unspecified reactive species
Protein science : a publication of the Protein Society 33:e5126 PubMed39073155
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 51:10194-10217 PubMed37638746
2023
Applications
Unspecified application
Species
Unspecified reactive species
Genesis (New York, N.Y. : 2000) 61:e23507 PubMed36656301
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular gastroenterology and hepatology 14:527-551 PubMed35643233
2022
Applications
Unspecified application
Species
Unspecified reactive species
PLoS genetics 17:e1009868 PubMed34752469
2021
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 3:363 PubMed32647372
2020
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasia (New York, N.Y.) 22:376-389 PubMed32629178
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature genetics 51:941-946 PubMed31152160
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com